$21.84
+1.0%Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
MD โข NYSE
| Pediatrix Medical Group, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
0.0 | -99.1M | -60.4M | 62.6M | 108M | -9.6M | 42.2M | 268.6M | 320.4M | 324.6M | 335.7M | 317.2M | 280.5M | 240.9M | 218M | 202.7M | 175.8M | 169.2M | 142.7M | 124.5M | |
0.0 | 33.2M | 36.2M | 35.6M | 32.1M | 28.4M | 25.9M | 111.3M | 102.9M | 89.3M | 64.2M | 46M | 40M | 30.8M | 25.3M | 22M | 16.7M | 13.2M | 10.6M | 9.5M | |
0.0 | -2.1M | 3.2M | -22.8M | -31.2M | 36.3M | -55.7M | -24.1M | -60.1M | 18.1M | 14.5M | 2.6M | 15.9M | 21.3M | 8.1M | 24.4M | 7.4M | -13.6M | -7M | -1.7M | |
0.0 | 11.9M | 12.3M | 16.1M | 19M | 39M | 33.4M | 38.7M | 29.6M | 34M | 32.1M | 31.7M | 31.3M | 28.4M | 27.1M | 25.7M | 24.3M | 20.8M | 18M | 10.2M | |
229.3M | 174.5M | 157.6M | 43.6M | -27.8M | 57.7M | 295.8M | -7.4M | 981K | 4M | -2.5M | -6.3M | 2.3M | 995K | 1.1M | 967K | 0.0 | -38.5M | -2M | 8.3M | |
(0.0) | (4.7M) | (30.8M) | (26.9M) | (54.7M) | (0.0) | (86.3M) | (185.4M) | (75.4M) | (176M) | (181M) | (161.8M) | (126.4M) | (129.6M) | (119.3M) | -88.6M | (113.2M) | (104.2M) | (79.1M) | (0.0) | |
41.8M | 88.2M | -11.6M | 31.8M | -23.4M | 52.7M | 16M | -97.1M | 117.6M | -26.2M | -75.4M | 31.4M | 35.4M | 3.2M | -8.5M | -35.1M | 17.1M | 30.4M | 26.3M | 26.6M | |
271.1M | 206.6M | 137.3M | 166.9M | 76.7M | 204.6M | 357.7M | 289.9M | 511.4M | 443.8M | 368.7M | 422.6M | 405.4M | 325.7M | 271M | 240.6M | 241.4M | 181.4M | 188.5M | 177.3M | |
INVESTING ACTIVITIES | ||||||||||||||||||||
(0.0) | -22M | -33.3M | -29.7M | -32.2M | -28.8M | -19.3M | -48.9M | -49.3M | -39.3M | -27.1M | -18.1M | -15.7M | -14.5M | -31.3M | -12.1M | -14.9M | -15.7M | -8.5M | -12.9M | |
(0.0) | -8.2M | -6.7M | -28.2M | -5.2M | -2.2M | -47M | -91.7M | -531.7M | -762.3M | -818.9M | -479.4M | -238M | -441M | -154.9M | -338.6M | -151.3M | -205.7M | -119.1M | -91.8M | |
(0.0) | -64.5M | -31.9M | -17.3M | -35.1M | -61.8M | -35.1M | -15.9M | -27.7M | -61M | -34M | -26.9M | -20.8M | -33.1M | -42.5M | -26.5M | -19.6M | -26.2M | -201.8M | -78.7M | |
0.0 | 52.5M | 22.9M | 16.9M | 16.5M | 33.4M | 51.1M | 13.7M | 25.4M | 41.3M | 32M | 20.7M | 11M | 28.1M | 38.2M | 15.6M | 22.7M | 24.7M | 238.6M | 21.3M | |
-18.3M | 6.8M | 807K | 1.4M | 2.9M | 874.9M | 152.7M | -18.4M | 6.7M | -19.7M | -2M | -6.1M | -9.8M | -446.1M | 0.0 | 0.0 | 0.0 | 68.3M | 0.0 | 6.1M | |
-18.3M | -35.4M | -48.2M | -57M | -53.1M | (815.5M) | (102.5M) | -142.8M | -576.6M | -821.2M | -848M | -503.6M | -263.5M | -460.5M | -190.6M | -361.6M | -163.1M | -222.9M | -90.8M | -155.9M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-83.5M | 1.9M | 4M | -83.1M | 2.1M | -1.5M | -134M | -285.9M | -46.9M | -39.8M | -214.9M | -445.6M | -23.2M | 28.8M | 31.4M | 22.5M | 18M | -188.3M | -72.6M | 29.9M | |
-20.8M | -15.4M | -19.1M | -405.2M | -762.7M | -1.2M | -239.5M | 129M | 145.3M | 427.9M | 713.3M | 540.8M | -117.1M | 112.5M | -119.9M | 96.2M | -89.8M | 137.2M | -460K | -908K | |
-86.7M | -1.7M | -919K | -88.5M | -4.7M | -8.5M | -145.3M | -302.2M | -70.2M | -61.8M | -235.1M | -488.4M | -51.9M | (0.0) | (0.0) | (0.0) | (0.0) | -200M | -100M | (0.0) | |
-3.2M | -1M | -10.6M | 732K | 407K | -1.5M | -19.5M | 2.5M | 14.6M | -6.5M | -15.5M | 45.3M | 8.2M | -3.7M | 470K | 2M | 5.8M | 4.1M | 8.6M | 8.1M | |
-107.5M | -14.5M | -25.7M | -487.6M | -760.1M | -4.2M | -393.1M | -170.6M | 89.7M | 381.6M | 482.9M | 97.8M | -132.1M | 137.5M | -88.1M | 120.8M | -66.1M | -47M | -64.4M | 37.1M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
145.3M | 156.7M | 63.4M | -377.6M | -736.5M | 1B | 67.1M | -23.5M | 24.5M | 4.1M | 3.6M | 16.8M | 9.9M | 2.7M | -7.7M | -252K | 12.2M | -88.5M | 33.3M | 58.4M | |
229.9M | 73.3M | 9.8M | 387.4M | 1.1B | 107.9M | 40.8M | 80.2M | 55.7M | 51.6M | 47.9M | 31.1M | 21.3M | 18.6M | 26.3M | 26.5M | 14.3M | 102.8M | 69.6M | 11.2M | |
375.2M | 229.9M | 73.3M | 9.8M | 387.4M | 1.1B | 107.9M | 56.7M | 80.2M | 55.7M | 51.6M | 47.9M | 31.1M | 21.3M | 18.6M | 26.3M | 26.5M | 14.3M | 102.9M | 69.6M | |
252.6M | 184.6M | 104M | 137.2M | 44.5M | 175.8M | 338.4M | 241.1M | 462.1M | 404.5M | 341.6M | 404.6M | 389.7M | 311.2M | 239.7M | 228.4M | 226.4M | 165.7M | 180M | 164.4M |
MD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 27, 2026 | March 25, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 19, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 19, 2026 | February 19, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 03, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 03, 2025 | November 03, 2025 | 2025 | |
8-K 8-K 2025 N/A | August 18, 2025 | August 18, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | August 05, 2025 | June 30, 2025 | 2025 |
Continue your MD research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.